Breast Cancer

High levels of inflammation, as well as high BMI and later-stage disease, may be predictors of weakness after chemotherapy treatment in older patients with breast cancer, which may hold potential in guiding treatment decisions.

The switch from private insurance to Medicare was a struggle — especially considering my need for cancer care — that was not solved by numerous phone calls, but by Twitter instead.

Looking back on my breast cancer experience, I contemplate what it means to thrive.

It’s been 20 years since my cancer diagnosis, and in that time, I’ve changed significantly.

After undergoing treatment for triple-negative breast cancer, I’m living my life with cautious optimism, and will always seek out joy.

Cancer tried to kill me, but I came back even stronger than ever.

A procedure that targets and freezes nerves that were damaged during a mastectomy may be a safe and effective method of relieving pain in breast cancer survivors.

The medical world has antidotes for many of the issues that arise from cancer treatments, so I learned to speak up about what I was experiencing.

Acupuncture has been shown to decrease cancer-related pain, and it most recently was recommended by several organizations for certain patients with breast cancer.

On the same day that I learned of my cancer progression, I also found out I had COVID-19. Here’s how I handled that dark period of life.

Seasoned journalist Katie Couric revealed that she received a breast cancer diagnosis in June and underwent treatment for the disease this summer.

After being diagnosed with breast cancer, I became a fierce advocate for myself.

I'm suggesting a new medical discipline called "previvology" that is dedicated to the detection of genetic mutations and the prevention or early detection of cancers that are associated with them.

The novel drug PY159 will be studied as a single agent and in combination with Keytruda for patients with certain solid tumors — including ovarian, pancreatic, lung, head and neck, colorectal and breast cancers.

I underwent cancer treatments during my lunch breaks at work. Looking back, I wish I took some time off.

I’m surviving cancer while getting older, too — that means I can no longer do some of the things I did when I was younger.

After I held my hand as my mom died, I wondered who would hold mine as I went through cancer.

While I’m usually a private person, it’s important to me to share my three bouts with cancer so that others will learn their bodies and their family history.

It’s good that celebrities with cancer raise awareness about the disease, but I think that they can do more.

An expert explains how antibody drug conjugates work to treat cancer.

Opting for hormonal or nonhormonal fertility preservation is unlikely to affect a woman’s risk for death or disease recurrence after receiving a diagnosis of breast cancer.

I never thought I’d admit experiencing fear of cancer recurrence, but at a recent medical appointment I realized that I struggle with this fear daily.

Black women were more likely to benefit from neoadjuvant endocrine therapy for early-stage breast cancer, however, their outcomes were inferior to White women when it came to late-stage disease, recent research showed.

Extra years with my family meant missing out on a free trip granted to patients with cancer who have children under the age of 18 — and I’m OK with that.

Although rates of pathologic complete response to neoadjuvant — also known as presurgical — chemotherapy were lower in men than women with breast cancer, this may highlight an area of further research of treating this cancer in men.

As “Pinktober” approaches, I’m spreading the message that breasts are not needed to live a full life after breast cancer surgery.

As National Previvor Day approaches, I’m getting back on my soapbox to discuss genetic testing and family histories of cancer. After all, these discussions could save lives.

Compared to physician’s choice of treatment, Trodelvy improved survival and quality of life in pretreated patients with HR positive/HER2 negative metastatic breast cancer.

Adding the novel drug oleclumab to Imfinzi and chemotherapy for the frontline treatment of advanced triple-negative breast cancer did not improve clinical outcomes, according to recent study findings.

When my daughter first started cancer treatment, she was brave, but after she understood how difficult it was, she was courageous in continuing.